Our primary area of research focuses on conditions that would fall under the category of inflammatory arthritis such as Rheumatoid Arthritis and Psoriatic Arthritis as well as inflammatory back conditions such as Ankylosing Spondylitis. We also run studies that look at Osteoarthritis, the most common form of the rheumatology conditions. In addition to this we have recently expanded our research portfolio to include undertaking studies relating to Connective Tissue Diseases. Our research in these areas varies from simple national registry and observational data collection studies to the more complex international Randomised Control Trials. Further development of our understanding of the rheumatology conditions and gaining access to new treatments to encourage optimal management of our patient's disease is at the forefront of our practice.
Our established team of researchers have run a wide range of National Institute of Health Research (NIHR), Clinical Research Network (CRN) portfolio and non-portfolio adopted studies over the past 10 years. Our research activity has a strong sense of local collaboration with our neighbouring Universities of Leeds and York as well as a long well established relationship with the University of Manchester and its links with the Arthritis Research UK charity. We take part in national registry research for Ankylosing Spondylitis and Rheumatoid Arthritis as well as other observational studies looking at Systemic Lupus Erythema, Scleroderma, Raynaud's, Vasculitis, Inflammatory Back Pain and the patient impact and treatment of these conditions.
Our Randomised Clinical Trials have largely focused on treatments of the big three conditions in Rheumatology that are Rheumatoid, Psoriatic and Osteo Arthrits. Our Clinical Trials often involve the use of existing licenced drugs such as those classified as Biologic's that target pathways, proteins and cells which trigger the damaging autoimmune response experienced by our patients. These studies involve using these drugs in a slightly different way to standard practice to try and promote more effective management of the target condition. We have also run studies that look at new drugs under development that are not licenced for use in the UK or available via standard treatment pathways.
Please click here to be taken to the NIHR Be Part of Research website where you can search for research studies that are currently being undertaken in our Speciality at our Trust.
Meet Our Team
We have a dedicated Rheumatology Research Team within York Hospital that comprises Research Nurse and one Clinical Trials Assistant. Our team is supported by a Lead Research Nurse for the Trust and our research studies are set up with the assistance of a Research Delivery Facilitator from the Research and Development team. We also have rheumatology research studies running at our Scarborough, Malton and Bridlington Hospitals by our colleagues in the Local Clinical Research Network's (CRN) Generic Research Team. Click here to be taken to the Generic Research Teams webpage.
Each member of the team has different levels of research and rheumatology experience and all are trained to national standards of Good Clinical Practice (GCP). To help deliver our research to the best standard our team is integrated into the core Rheumatology clinical service at our York and Selby Hospitals. We are also fortunate enough to have the NIHR CRN MSK Speciality Lead for the Yorkshire and Humber Region, Dr Mike Green based at our York Hospital who actively directs the teams research.
Meet our York Team Members
|Name, Job Title
|Dr Michael Green, Consultant Rheumatologist and Research Lead
|Dr Andrew, Brown, Consultant Rheumatologist and Senior Lecturer at the Hull York Medical School
|Dr Mark Quinn, Consultant Rheumatologist and Clinical Director for the Directorate
|Dr Esme Ferguson, Consultant Rheumatologist
|Dr Marilyn Rogers, Consultant Rheumatologist
Arthritis Research UK; Information on symptoms, treatments and research relating to arthritis conditions
British Society of Rheumatology Biologics Register - Rheumatoid Arthritis; National Registry for the use of Biologic Drugs in Rheumatoid Arthritis
British Society of Rheumatology Biologics Register - Ankylosing Spondylitis; National Registry for the use of Biologic Drugs in Ankylosing Spondylitis
Leeds Biomedical Research Centre; World leading centre for research into musculoskeletal disease
National Institute of Health Research; Information about Research, the Clinical Research Networks, Funding and Support and much more